Antibiotics

Pharmalot Ed Silverman

‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.

Pharmalot Ed Silverman

In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries

First Opinion Harry Rhodes

FDA needs to follow through on its plan to ban carbadox in animal feed

Pharmalot Ed Silverman

U.K. readies a Netflix-style subscription payment model for badly needed antibiotics

Pharmalot Ed Silverman

McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies

Pharmalot Ed Silverman

A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds

First Opinion Podcast Patrick Skerrett

Listen: An antibiotic expert on her body’s stinging betrayal by these drugs

First Opinion Natalie Ma

My company is developing new antibiotics. My resistant infection showed me we need them now

Pharmalot Ed Silverman

Older Americans bore the brunt of antibiotic-resistant infections, study finds

In the Lab Peter Andrey Smith

In the hunt for novel antibiotics, will new technology overtake underwater exploration?

Pharma Ed Silverman

STAT+ Conversations: the revitalization of the antibiotic drug pipeline

Pharma Ed Silverman

Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?

Pharmalot Ed Silverman

Lawmakers revive legislation to accelerate the development of new antibiotics

Opinions+ Peter Bak

Investment in antimicrobials was up in 2020, but much work remains

Pharmalot Ed Silverman

WHO warns the world is still failing to develop desperately needed antibiotics

First Opinion Podcast Patrick Skerrett

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

Pharmalot Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Pharmalot Ed Silverman

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

Pharmalot Ed Silverman

Antibiotic prescribing during the pandemic raises concern about drug resistance

First Opinion Michelle McMurry-Heath

The Biden administration’s pandemic agenda must not ignore superbugs

Politics Matthew Herper

Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria

Health Matthew Herper and Ed Silverman

Virtual Event: Facing the crisis of drug-resistant germs

Pharmalot Ed Silverman

Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline

First Opinion Jowa (Zhuo) Shi and Ateev Mehrotra

Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19

Pharmalot Ed Silverman

antibiotics

Most Read

Pharma’s ambitious new antibiotic venture fund makes its first investments

New global data showing 1.27 million deaths a year reveal the urgent need to address antimicrobial resistance

In the calm before the superbug storm, the world needs to prepare

The PASTEUR Act can help win the war against superbugs

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

Antibiotic resistance: the hidden threat lurking behind Covid-19

The superbug Candida auris is giving rise to warnings — and big questions

Patients with feared superbug shed large amounts of it from their skin, study says

All Coverage

‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.

In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries

FDA needs to follow through on its plan to ban carbadox in animal feed

U.K. readies a Netflix-style subscription payment model for badly needed antibiotics

McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies

A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds

Listen: An antibiotic expert on her body’s stinging betrayal by these drugs

My company is developing new antibiotics. My resistant infection showed me we need them now

Older Americans bore the brunt of antibiotic-resistant infections, study finds

In the hunt for novel antibiotics, will new technology overtake underwater exploration?

STAT+ Conversations: the revitalization of the antibiotic drug pipeline

Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?

Lawmakers revive legislation to accelerate the development of new antibiotics

Investment in antimicrobials was up in 2020, but much work remains

WHO warns the world is still failing to develop desperately needed antibiotics

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

Antibiotic prescribing during the pandemic raises concern about drug resistance

The Biden administration’s pandemic agenda must not ignore superbugs

Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria

Virtual Event: Facing the crisis of drug-resistant germs

Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline

Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19

New bill would create a subscription payment model to jumpstart antibiotic development

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day